Insider · CIK 0001863107

Bender Jeremy

Reports to the SEC for 5 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001863107

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-28	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+39K sh	—	—	38,950
2026-07-07	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2026-07-07	AURAAura Biosciences, Inc.A Award	Director	AAward	+30K sh	—	—	30,000
2026-04-23	DAWNDay One Biopharmaceuticals, Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−300K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−148K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−81.8K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−397K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−286K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−300K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−244K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−14.3K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−222K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−20.2K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−808K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−18.2K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−129K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−205K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−355K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−286K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−1.46M sh	—	—	0
2026-02-26	MREOMereo BioPharma Group plc · Share Options (Right to buy)A Award	Director	AAward	+66K sh	—	—	66,000
2026-02-26	MREOMereo BioPharma Group plc · Deferred Restricted Stock UnitsA Award	Director	AAward	+118K sh	—	—	117,533
2026-02-17	DAWNDay One Biopharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−15.5K sh	$11.60	−$179K	204,603
2026-02-15	DAWNDay One Biopharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+11.7K sh	—	—	193,603
2026-02-15	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−11.7K sh	—	—	128,565
2026-02-15	DAWNDay One Biopharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+4,750 sh	—	—	181,915
2026-02-15	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−14.8K sh	—	—	222,188
2026-02-15	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−4,750 sh	—	—	14,250
2026-02-15	DAWNDay One Biopharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+11.7K sh	—	—	205,290
2026-02-15	DAWNDay One Biopharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+14.8K sh	—	—	220,102
2026-02-15	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−11.7K sh	—	—	81,816
2026-01-30	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+237K sh	—	—	237,000
2026-01-30	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+355K sh	—	—	355,000
2025-11-25	DAWNDay One Biopharmaceuticals, Inc.G Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	+300K sh	—	—	300,000
2025-11-25	DAWNDay One Biopharmaceuticals, Inc.G Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	−300K sh	—	—	808,285
2025-11-25	DAWNDay One Biopharmaceuticals, Inc.G Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	−300K sh	—	—	1,108,285
2025-11-25	DAWNDay One Biopharmaceuticals, Inc.G Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	+300K sh	—	—	300,000
2025-11-25	DAWNDay One Biopharmaceuticals, Inc.G Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	−7,225 sh	—	—	7,225
2025-11-25	DAWNDay One Biopharmaceuticals, Inc.G Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	−7,225 sh	—	—	0
2025-11-17	DAWNDay One Biopharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−15.9K sh	$8.91	−$142K	177,165
2025-11-15	DAWNDay One Biopharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+3,570 sh	—	—	164,935
2025-11-15	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−4,750 sh	—	—	19,000
2025-11-15	DAWNDay One Biopharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+4,750 sh	—	—	169,685
2025-11-15	DAWNDay One Biopharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+11.7K sh	—	—	181,372
2025-11-15	DAWNDay One Biopharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+11.7K sh	—	—	193,059
2025-11-15	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−3,570 sh	—	—	0
2025-11-15	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−11.7K sh	—	—	93,504
2025-11-15	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−11.7K sh	—	—	140,252
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−397K sh	—	—	0
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−1.46M sh	—	—	0

Recent filings

Accepted (ET)
Jul 294
Bender Jeremy0001470831-26-000738
SEC(opens sec.gov)
Jul 84
Bender Jeremy0001193125-26-298542
SEC(opens sec.gov)
Apr 234
Bender Jeremy0001863107-26-000005
SEC(opens sec.gov)

Companies

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116